Seto T - Search Results

1

Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.

Ando M, Okamoto I, Yamamoto N, Takeda K, Tamura K, Seto T, Ariyoshi Y, Fukuoka M. Ando M, et al. Among authors: seto t. J Clin Oncol. 2006 Jun 1;24(16):2549-56. doi: 10.1200/JCO.2005.04.9866. J Clin Oncol. 2006. PMID: 16735708

2

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study.

Seto T, Takezako Y, Nakamura H, Takeda K, Inoue F, Semba H, Eguchi K. Seto T, et al. Int J Clin Oncol. 2004 Oct;9(5):378-82. doi: 10.1007/s10147-004-0422-4. Int J Clin Oncol. 2004. PMID: 15549588 Clinical Trial.

3

Gefitinib-induced lung injury successfully treated with high-dose corticosteroids.

Seto T, Seki N, Uematsu K, Tanigaki T, Shioya S, Koboyashi T, Umemura S, Eguchi K. Seto T, et al. Respirology. 2006 Jan;11(1):113-6. doi: 10.1111/j.1440-1843.2006.00794.x. Respirology. 2006. PMID: 16423212

4

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).

Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M. Kudoh S, et al. Among authors: seto t. J Clin Oncol. 2006 Aug 1;24(22):3657-63. doi: 10.1200/JCO.2006.06.1044. J Clin Oncol. 2006. PMID: 16877734 Clinical Trial.

5

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, Okamoto H, Ogura T, Yokoyama A, Seki N, Asaka-Amano Y, Harada M, Tagawa A, Kunikane H, Yokoba M, Uematsu K, Kuriyama T, Kuroiwa Y, Watanabe K; Thoracic Oncology Research Group Study 0301. Onoda S, et al. Among authors: seto t. J Clin Oncol. 2006 Dec 1;24(34):5448-53. doi: 10.1200/JCO.2006.08.4145. J Clin Oncol. 2006. PMID: 17135647 Clinical Trial.

6

A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.

Kiura K, Nakagawa K, Shinkai T, Eguchi K, Ohe Y, Yamamoto N, Tsuboi M, Yokota S, Seto T, Jiang H, Nishio K, Saijo N, Fukuoka M. Kiura K, et al. Among authors: seto t. J Thorac Oncol. 2008 Apr;3(4):386-93. doi: 10.1097/JTO.0b013e318168d228. J Thorac Oncol. 2008. PMID: 18379357 Free article. Clinical Trial.

7

Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.

Seto T, Yamanaka T, Nakano M, Ota M, Maruyama R, Okamoto T, Wataya H, Uematsu K, Seki N, Eguchi K, Semba H, Ichinose Y. Seto T, et al. J Thorac Oncol. 2008 Jun;3(6):637-42. doi: 10.1097/JTO.0b013e318174e070. J Thorac Oncol. 2008. PMID: 18520804 Free article. Clinical Trial.

8

Prognostic factors in previously treated non-small cell lung cancer patients with and without a positive response to the subsequent treatment with gefitinib.

Wataya H, Okamoto T, Maruyama R, Seto T, Yamazaki K, Tagawa T, Fukuyama S, Osoegawa A, Ikeda J, Nishimura M, Yamanaka T, Ichinose Y. Wataya H, et al. Among authors: seto t. Lung Cancer. 2009 Jun;64(3):341-5. doi: 10.1016/j.lungcan.2008.09.005. Epub 2008 Nov 7. Lung Cancer. 2009. PMID: 18995926

9

Treatment after the failure of gefitinib in patients with advanced or recurrent non-small cell lung cancer.

Maruyama R, Wataya H, Seto T, Ichinose Y. Maruyama R, et al. Among authors: seto t. Anticancer Res. 2009 Oct;29(10):4217-21. Anticancer Res. 2009. PMID: 19846976 Free article.

10

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M; West Japan Oncology Group. Mitsudomi T, et al. Among authors: seto t. Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

838 results

Search Page

Filters